CASTROLINDNSECastrol India Limited· Petroleum ProductsCriticalNegative
Announced Fri, 10 Oct, 2025 · 15:24 IST

Castrol India: Managing Director resigns; internal executive named Interim CEO

Kmp ResignedManagement Changes View source PDFExplain this filing

CASTROLIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹200.00
prior close
₹200.45
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.6%-0.3% vs market
Lubricants peers, median of 5sector-0.2%+0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Smallcap 250 and 0.5 pts more than its Lubricants peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3+0.6-0.3-0.2+0.5
Next day
-0.0+0.3-0.3-0.2+0.2
2d
-0.5-0.6+0.1-2.6+2.1
3d
+2.3+0.3+2.0-1.1+3.4
4d
+0.0+0.6-0.6-1.0+1.0
5d
-0.6+0.4-1.0-1.7+1.2
1w
+0.2+1.6-1.4-1.4+1.6
15d
-2.0+2.5-4.5-3.4+1.5
1m
-4.5+0.1-4.5-5.3+0.9
2m
-7.0-4.9-2.0-9.7+2.8
3m
-6.4-5.3-1.1-6.4+0.0
UpDownMarket · Nifty Smallcap 250Sector · Lubricants peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Castrol India's Managing Director Kedar Lele will leave the company at the close of business on 31 December 2025 to pursue opportunities outside the organisation. From 1 January 2026, Saugata Basuray, currently Wholetime Director and Head of B2C Sales, will also act as Interim CEO until a new Managing Director is appointed.

Likely market impact

Leadership change from 1 January 2026 may create uncertainty, but an internal interim CEO should provide continuity until a permanent MD is appointed.